Literature DB >> 26998280

Expression of calcitonin gene-related peptide, adenosine A2a receptor and adenosine A1 receptor in experiment rat migraine models.

Wenxian Lu1, Bin Li2, Jinbo Chen2, Yipeng Su2, Xiaomeng Dong2, Xinyang Su3, Lixiang Gao3.   

Abstract

A migraine is a disabling neurovascular disorder characterized by a unilateral throbbing headache that lasts from 4 to 72 h. The headache is often accompanied by nausea, vomiting, phonophobia and photophobia, and may be worsened by physical exercise. The trigeminovascular system (TVS) is speculated to have an important role in migraines, although the pathophysiology of this disorder remains to be elucidated. Trigeminal ganglion (TG) and spinal trigeminal nucleus caudalis (TNC) are important components of the TVS. Several clinical cases have provided evidence for the involvement of the brainstem in migraine initiation. Electrical stimulation of the trigeminal ganglion (ESTG) in rats can activate TVS during a migraine attack. Calcitonin gene-related peptide (CGRP) is an important vasoactive compound produced following TVS activation. Numerous studies have revealed that adenosine and its receptors have an important role in pain transmission and regulation process. However, only a few studies have examined whether adenosine A2a receptor (A2aR) and adenosine A1 receptor (A1R) are involved in migraine and nociceptive pathways. In the present study, CGRP, A2aR and A1R expression levels were detected in the TG and TNC of ESTG models through reverse transcription-quantitative polymerase chain reaction and western blot analysis. Tianshu capsule (TSC), a type of Chinese medicine, was also used in the ESTG rat models to examine its influence on the three proteins. Results demonstrated that CGRP, A2aR and A1R mediated pain transmission and the regulation process during migraine and the expression of the three proteins was regulated by TSC.

Entities:  

Keywords:  Tian Shu capsule; adenosine 2a receptor; adenosine A1 receptor; calcitonin gene-related peptide; electrical stimulation of trigeminal ganglion models; migraine

Year:  2016        PMID: 26998280      PMCID: PMC4774314          DOI: 10.3892/br.2016.591

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  26 in total

1.  Systemic adenosine infusion reduces the area of tactile allodynia in neuropathic pain following peripheral nerve injury: a multi-centre, placebo-controlled study.

Authors:  K F Sjölund; M Belfrage; R Karlsten; M Segerdahl; S Arnér; T Gordh; A Solevi
Journal:  Eur J Pain       Date:  2001       Impact factor: 3.931

Review 2.  Recent advances in understanding migraine mechanisms, molecules and therapeutics.

Authors:  Peter J Goadsby
Journal:  Trends Mol Med       Date:  2006-12-01       Impact factor: 11.951

3.  Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.

Authors:  M J Moreno; R Abounader; E Hébert; H Doods; E Hamel
Journal:  Neuropharmacology       Date:  2002-03       Impact factor: 5.250

Review 4.  CGRP and its receptors provide new insights into migraine pathophysiology.

Authors:  Tony W Ho; Lars Edvinsson; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2010-09-07       Impact factor: 42.937

5.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.

Authors:  C Ledent; J M Vaugeois; S N Schiffmann; T Pedrazzini; M El Yacoubi; J J Vanderhaeghen; J Costentin; J K Heath; G Vassart; M Parmentier
Journal:  Nature       Date:  1997-08-14       Impact factor: 49.962

Review 6.  Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.

Authors:  Reinaldo Naoto Takahashi; Fabricio Alano Pamplona; Rui Daniel Schroder Prediger
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.

Authors:  Jiang-Fan Chen; Patricia K Sonsalla; Felicita Pedata; Alessia Melani; Maria Rosaria Domenici; Patrizia Popoli; Jonathan Geiger; Luísa V Lopes; Alexandre de Mendonça
Journal:  Prog Neurobiol       Date:  2007-09-29       Impact factor: 11.685

Review 8.  Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain.

Authors:  Rodrigo Noseda; Rami Burstein
Journal:  Pain       Date:  2013-07-25       Impact factor: 6.961

9.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

Review 10.  The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.

Authors:  Carlos M Villalón; Jes Olesen
Journal:  Pharmacol Ther       Date:  2009-09-29       Impact factor: 12.310

View more
  4 in total

Review 1.  A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of Migraine.

Authors:  Kaveh Ebahimzadeh; Mahdi Gholipour; Mohammad Samadian; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2021-01-14       Impact factor: 3.444

Review 2.  The Role of Adenosine Signaling in Headache: A Review.

Authors:  Nathan T Fried; Melanie B Elliott; Michael L Oshinsky
Journal:  Brain Sci       Date:  2017-03-13

3.  Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine.

Authors:  Kristian A Haanes; Alejandro Labastida-Ramírez; Kayi Y Chan; René de Vries; Brian Shook; Paul Jackson; Jimmy Zhang; Christopher M Flores; Alexander H J Danser; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2018-05-25       Impact factor: 7.277

Review 4.  Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies.

Authors:  Janu Thuraiaiyah; Lili Kokoti; Mohammad Al-Mahdi Al-Karagholi; Messoud Ashina
Journal:  J Headache Pain       Date:  2022-04-05       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.